PatientsVille.com Logo

PatientsVille

Dextroamphet Side Effects

Common Dextroamphet Side Effects


The most commonly reported Dextroamphet side effects (click to view or check a box to report):

Product Substitution Issue (28)
Product Quality Issue (21)
Headache (16)
Death (16)
Cardio-respiratory Arrest (14)
Nausea (12)
Somnolence (11)
Disturbance In Attention (10)
Fatigue (8)
Anxiety (8)
Aggression (8)
Feeling Abnormal (7)
Depression (7)
Hyperhidrosis (7)
Impaired Work Ability (7)
Palpitations (6)
Rash (6)
Insomnia (6)
Blood Pressure Increased (6)
Overdose (6)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Dextroamphet Side Effects Reported to FDA

The following Dextroamphet reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Dextroamphet on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Anxiety, Feeling Abnormal, Feeling Jittery, Product Quality Issue, Product Substitution Issue
This is a report of a 29-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: attention deficit/hyperactivity disorder, who was treated with Dextroamphetamine Sulfa Usp Xr (dosage: NA, start time: Feb 17, 2014), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Anxiety
  • Feeling Abnormal
  • Feeling Jittery
  • Product Quality Issue
  • Product Substitution Issue
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Dextroamphetamine Sulfa Usp Xr treatment in female patients, resulting in anxiety side effect.

Skin Odour Abnormal, Breath Odour, Product Odour Abnormal
This report suggests a potential Dextroamphetamine Skin Odour Abnormal, Breath Odour, Product Odour Abnormal side effect(s) that can have serious consequences. A 30-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: attention deficit/hyperactivity disorder and used Dextroamphetamine (dosage: NA) starting Feb 03, 2014. Soon after starting Dextroamphetamine the patient began experiencing various side effects, including:
  • Skin Odour Abnormal
  • Breath Odour
  • Product Odour Abnormal
Drugs used concurrently: NA. Although Dextroamphetamine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as skin odour abnormal, may still occur.

Product Substitution Issue, Depressed Mood, Fatigue, Posture Abnormal, Bedridden, Chest Pain, Myalgia, Bone Pain
This Product Substitution Issue, Depressed Mood, Fatigue, Posture Abnormal, Bedridden, Chest Pain, Myalgia, Bone Pain problem was reported by a pharmacist from US. A 24-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Feb 21, 2014 this consumer started treatment with Dextroamphetamine-amphetamine Xr (dosage: 1 Capsule Qam Oral). The following drugs were being taken at the same time: NA. When commencing Dextroamphetamine-amphetamine Xr, the patient experienced the following unwanted symptoms/side effects:
  • Product Substitution Issue
  • Depressed Mood
  • Fatigue
  • Posture Abnormal
  • Bedridden
  • Chest Pain
  • Myalgia
  • Bone Pain
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as product substitution issue, may become evident only after a product is in use by the general population.

Tic, Abnormal Behaviour
This is a report of a 6-year-old male patient (weight: NA) from US. The patient developed the following symptoms/conditions: attention deficit/hyperactivity disorder,psychomotor hyperactivity and was treated with Dextroamphetamine-amphetamine Xr (dosage: 1 Qd Orally) starting Jul 02, 2013. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Tic
  • Abnormal Behaviour
This opens a possibility that Dextroamphetamine-amphetamine Xr treatment could cause the above reactions, including tic, and some male subjects may be more susceptible.


Asthenia
A 36-year-old male patient (weight: NA) from US with the following symptoms/conditions: attention deficit/hyperactivity disorder,narcolepsy,depression,diabetes mellitus,hypertension,convulsion started Dextroamphetamine Sulfate treatment (dosage: 3 Caps In Am And 3 Caps In Pm) on Oct 19, 2013. Soon after starting Dextroamphetamine Sulfate treatment, the subject experienced various side effects, including:
  • Asthenia
Concurrently used drugs: NA. This finding indicates that some male patients could be more vulnerable to Dextroamphetamine Sulfate.

Oropharyngeal Pain, Myalgia, Headache
A 54-year-old male patient from US (weight: NA) experienced symptoms, such as: fatigue and was treated with Dextroamphetamine Sulfate(dosage: 10 Mg, Unk). The treatment was initiated on 201304. After that a consumer reported the following side effect(s):
  • Oropharyngeal Pain
  • Myalgia
  • Headache
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Dextroamphetamine Sulfate efficacy:
  • Synthyroid (Unk)


Anxiety
In this report, Dextroamphetamine Sulfate Extended-release was administered for the following condition: attention deficit/hyperactivity disorder.A 28-year-old male consumer from US (weight: NA) started Dextroamphetamine Sulfate Extended-release treatment (dosage: 10 Mg, Bid) on 201308.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Anxiety
A possible interaction with other drugs could have contributed to this reaction:
  • Magnesium (500 Mg, Qd)
  • Dextroamphetamine /00016601/ (Unk)
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Dextroamphetamine Sulfate Extended-release treatment could be related to the listed above side effect(s).

Anger, Mood Swings, Disturbance In Attention, Impulsive Behaviour, Condition Aggravated, Product Substitution Issue
This is a report of the following Dextroamphetamine side effect(s):
  • Anger
  • Mood Swings
  • Disturbance In Attention
  • Impulsive Behaviour
  • Condition Aggravated
  • Product Substitution Issue
A 6-year-old male patient from US (weight: NA) presented with the following condition: attention deficit/hyperactivity disorder and received a treatment with Dextroamphetamine (dosage: NA) starting: Nov 12, 2013.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Dextroamphetamine treatment could be associated with the listed above side effect(s).

Headache, Abdominal Pain Upper, Product Substitution Issue, Educational Problem
This Dextroamphetamine report was submitted by a 9-year-old male consumer from US (weight: NA). The patient was diagnosed with: attention deficit/hyperactivity disorder and Dextroamphetamine was administered (dosage: NA) starting: NS. The consumer developed a set of symptoms:
  • Headache
  • Abdominal Pain Upper
  • Product Substitution Issue
  • Educational Problem
Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Dextroamphetamine treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Product Substitution Issue, Migraine
This is a report of a possible correlation between Dextroamphetamine Xr 15mg use and the following symptoms/side effect(s):
  • Product Substitution Issue
  • Migraine
which could contribute to an assessment of Dextroamphetamine Xr 15mg risk profile.A 13-year-old male consumer from US (weight: NA) was suffering from attention deficit/hyperactivity disorder and was treated with Dextroamphetamine Xr 15mg (dosage: NA) starting Mar 17, 2006.Other concurrent medications: NA.

Product Substitution Issue, Disease Recurrence
A 24-year-old female patient from US (weight: NA) presented with the following symptoms: attention deficit/hyperactivity disorder and after a treatment with Dextroamphetamine (dosage: 2caps Qd Oral) experienced the following side effect(s):
  • Product Substitution Issue
  • Disease Recurrence
The treatment was started on Aug 15, 2013. Dextroamphetamine was used in combination with the following drugs: NA.This report could alert potential Dextroamphetamine consumers.

Dyspnoea, Pulmonary Hypertension
In this report, a 73-year-old female patient from US (weight: NA) was affected by a possible Dextroamphetamine Sr side effect.The patient was diagnosed with attention deficit/hyperactivity disorder. After a treatment with Dextroamphetamine Sr (dosage: Up To 60 Mg/day, Tid, Oral, start date: NS), the patient experienced the following side effect(s):
  • Dyspnoea
  • Pulmonary Hypertension
The following simultaneously used drugs could have led to this reaction:
  • Lisinopril
  • Percocet
The findings here stress that side effects should be taken into consideration when evaluating a Dextroamphetamine Sr treatment.

Constipation, Tinnitus
This is a report of a 35-year-old male patient from US (weight: NA), who used Dextroamphetamine (dosage: NA) for a treatment of attention deficit/hyperactivity disorder. After starting a treatment on 2001, the patient experienced the following side effect(s):
  • Constipation
  • Tinnitus
The following drugs could possibly have interacted with the Dextroamphetamine treatment NA.Taken together, these observations suggest that a Dextroamphetamine treatment could be related to side effect(s), such as Constipation, Tinnitus.

Blood Potassium Decreased, Electrocardiogram Qt Prolonged, Rhabdomyolysis, Metabolic Acidosis, Dehydration, Inadequate Analgesia
This blood potassium decreased side effect was reported by a physician from COUNTRY NOT SPECIFIED. A 44-year-old female patient (weight:NA) experienced the following symptoms/conditions: attention deficit/hyperactivity disorder,alcohol use. The patient was prescribed Dextroamphetamine Sulfate (dosage: 1 Dose, 1 Hour Before Exercise.), which was started on NS. Concurrently used drugs:
  • Alcohol (ethanol) (3 Drinks, 4 Hours After Dextroamphetamine Dose.)
When starting to take Dextroamphetamine Sulfate the consumer reported the following symptoms:
  • Blood Potassium Decreased
  • Electrocardiogram Qt Prolonged
  • Rhabdomyolysis
  • Metabolic Acidosis
  • Dehydration
  • Inadequate Analgesia
The patient was hospitalized. These side effects may potentially be related to Dextroamphetamine Sulfate.

Rhabdomyolysis
This is a Dextroamphetamine Sulfate side effect report of a 44-year-old female patient (weight:NA) from US, suffering from the following symptoms/conditions: attention deficit/hyperactivity disorder, who was treated with Dextroamphetamine Sulfate (dosage:NA, start time: NS), combined with: NA., and developed a serious reaction and a rhabdomyolysis side effect. The patient presented with:
  • Rhabdomyolysis
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Dextroamphetamine Sulfate treatment in female patients suffering from attention deficit/hyperactivity disorder, resulting in rhabdomyolysis.

Rhabdomyolysis
This report suggests a potential Dextroamphetamine Sulfate rhabdomyolysis side effect(s) that can have serious consequences. A 44-year-old female patient from US (weight:NA) was diagnosed with the following health condition(s): attention deficit/hyperactivity disorder and used Dextroamphetamine Sulfate (dosage: NA) starting NS. Soon after starting Dextroamphetamine Sulfate the patient began experiencing various side effects, including:
  • Rhabdomyolysis
Drugs used concurrently:NA. Although Dextroamphetamine Sulfate demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as rhabdomyolysis, may still occur.

Adrenal Insufficiency
This adrenal insufficiency problem was reported by a health professional from US. A 42-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): attention deficit/hyperactivity disorder.On May 01, 2012 a consumer started treatment with Dextroamphetamine (dosage: NA). The following drugs/medications were being taken at the same time: NA. When commencing Dextroamphetamine, the patient experienced the following unwanted symptoms /side effects:
  • Adrenal Insufficiency
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as adrenal insufficiency, may become evident only after a product is in use by the general population.

Amnesia, Disability, Somnolence, Feeling Abnormal, Product Quality Issue
This is a Dextroamphetamine Sulfate (aellc) side effect report of a 62-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: attention deficit/hyperactivity disorder and was treated with Dextroamphetamine Sulfate (aellc) (dosage: 30 Mg, Daily) starting 201303. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Amnesia
  • Disability
  • Somnolence
  • Feeling Abnormal
  • Product Quality Issue
This opens a possibility that Dextroamphetamine Sulfate (aellc) could cause amnesia and that some female patients may be more susceptible.

Asthenia, Listless, Feeling Abnormal
A 47-year-old female patient (weight: NA) from US with the following symptoms: NA started Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphe treatment (dosage: NA) on Feb 12, 2013. Soon after starting Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphe treatment, the consumer experienced several side effects, including:
  • Asthenia
  • Listless
  • Feeling Abnormal
. Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphe side effects, such as asthenia.

Rhabdomyolysis
This rhabdomyolysis side effect was reported by a health professional from US. A 44-year-old female patient (weight:NA) experienced the following symptoms/conditions: attention deficit/hyperactivity disorder.The patient was prescribed Dextroamphetamine (dosage: NA), which was started on NS. Concurrently used drugs:
  • Alcohol (3 Beverages)
.When starting to take Dextroamphetamine the consumer reported symptoms, such as:
  • Rhabdomyolysis
These side effects may potentially be related to Dextroamphetamine. The patient was hospitalized.

Rash Maculo-papular, Lip Oedema, Face Oedema
This is a report of a 22-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: attention deficit/hyperactivity disorder, who was treated with Dextroamphetamine Mixed Salter 20mg Actavis El (dosage: NA, start time: Nov 16, 2012), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Rash Maculo-papular
  • Lip Oedema
  • Face Oedema
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Dextroamphetamine Mixed Salter 20mg Actavis El treatment in female patients, resulting in rash maculo-papular side effect.

Rash, Eye Swelling, Product Substitution Issue
This report suggests a potential Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphe Rash, Eye Swelling, Product Substitution Issue side effect(s) that can have serious consequences. A 35-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: attention deficit/hyperactivity disorder and used Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphe (dosage: NA) starting Jan 15, 2013. Soon after starting Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphe the patient began experiencing various side effects, including:
  • Rash
  • Eye Swelling
  • Product Substitution Issue
Drugs used concurrently: NA. Although Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphe demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as rash, may still occur.

Product Quality Issue, Cardiac Disorder, Chest Pain, Dizziness, Dyspnoea
This Product Quality Issue, Cardiac Disorder, Chest Pain, Dizziness, Dyspnoea problem was reported by a consumer or non-health professional from US. A 37-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: attention deficit/hyperactivity disorder. On Aug 01, 2002 this consumer started treatment with Dextroamphetamine (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Dextroamphetamine, the patient experienced the following unwanted symptoms/side effects:
  • Product Quality Issue
  • Cardiac Disorder
  • Chest Pain
  • Dizziness
  • Dyspnoea
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as product quality issue, may become evident only after a product is in use by the general population.

Nausea
This is a report of a 51-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: attention deficit/hyperactivity disorder and was treated with Dextroamphetamine Sulfate Extended-release (dosage: 2 Caps Bid) starting 2010. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Nausea
This opens a possibility that Dextroamphetamine Sulfate Extended-release treatment could cause the above reactions, including nausea, and some female subjects may be more susceptible.

Toxicity To Various Agents, Pneumonia, Diarrhoea, Dehydration, Chromaturia
A female patient (weight: NA) from US with the following symptoms/conditions: bipolar disorder started Dextroamphetamine Sulfate treatment (dosage: NA) on NS. Soon after starting Dextroamphetamine Sulfate treatment, the subject experienced various side effects, including:
  • Toxicity To Various Agents
  • Pneumonia
  • Diarrhoea
  • Dehydration
  • Chromaturia
Concurrently used drugs:
  • Omeprazole
  • Seroquel
  • Gabapentin (900 Milligram Daily;)
  • Oxycodone (Every 4-6 Hours)
  • Zoloft
  • Hydrochlorothiazide
  • Levaquin
This finding indicates that some female patients could be more vulnerable to Dextroamphetamine Sulfate.

1 of 8 



Top 10 Dextroamphet Side Effects for Women

Women Side EffectsReports
Product Substitution Issue 14
Product Quality Issue 13
Headache 12
Nausea 10
Somnolence 9
Disturbance In Attention 6
Feeling Abnormal 6
Depression 5
Insomnia 5
Palpitations 5

Top 10 Dextroamphet Side Effects for Men

Men Side EffectsReports
Product Substitution Issue 14
Product Quality Issue 7
Overdose 6
Aggression 5
Tic 5
Anxiety 4
Death 4
Disturbance In Attention 4
Fatigue 4
Headache 4

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Dextroamphet Side Effects

    Did You Have a Dextroamphet Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Dextroamphet for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Dextroamphet Safety Alerts, Active Ingredients, Usage Information

    NDC0115-1328
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameDextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfa Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfa
    NameCAPSULE, EXTENDED RELEASE
    Dosage FormORAL
    Route20131217
    On market sinceGlobal Pharmaceuticals, Division of Impax Laboratories Inc.
    LabelerAMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAM
    Active Ingredient(s)1.25; 1.25; 1.25; 1.25
    Strength(s)mg/1; mg/1; mg/1; mg/1
    Unit(s)Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous Syste
    Pharma Class

    More About Dextroamphet

    Side Effects reported to FDA: 184

    Dextroamphet safety alerts: 2009 2008 2006

    Reported deaths: 18

    Reported hospitalizations: 6

    Dextroamphetamine, Amphetamine 20mg Tablets

    Dextroamphetamine Saccharate
    Amphetamine Aspartate
    Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of a Single Entity Amphetamine Product)

    Audience: Pharmacists, consumers

    [Posted 08/14/2009] Barr Laboratories, Inc. issued a voluntary recall of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of a Single Entity Amphetamine Product) 20mg Tablets, 100 count bottles, lot number 311756. The product is being recalled because the affected lot may contain some tablets exceeding weight requirements which may lead to super-potent tablets.

    Clinically significant adverse reactions to a supratherapeutic dose could include cardiovascular, neurologic, psychiatric and gastrointestinal reactions. Customers who have this lot in their possession are instructed to cease using the product and return it to their pharmacy/distributor.

    [08/13/2009 - Press Release - Barr Laboratories, Inc.]

    Latest Dextroamphet clinical trials

    Dextroamphet Reviews

    No reviews, be a first to report a side effect via side effect reporting form